Literature DB >> 23517492

Pressure sore-like ulcers on acneiform papules caused by EGFR inhibitors.

Saori Miyawaki1, Mikiko Tohyama, Kazunori Irifune, Ryouji Ito, Koji Sayama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23517492      PMCID: PMC7950907          DOI: 10.1111/iwj.12070

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


× No keyword cloud information.
  5 in total

Review 1.  Targeting the epidermal growth factor receptor for cancer therapy.

Authors:  John Mendelsohn
Journal:  J Clin Oncol       Date:  2002-09-15       Impact factor: 44.544

2.  EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation.

Authors:  D Peus; L Hamacher; M R Pittelkow
Journal:  J Invest Dermatol       Date:  1997-12       Impact factor: 8.551

Review 3.  The management of skin reactions in cancer patients receiving epidermal growth factor receptor targeted therapies.

Authors:  Siegfried Segaert; Josep Tabernero; Olivier Chosidow; Thomas Dirschka; Joern Elsner; Luca Mancini; Tim Maughan; Jean-Fran Ois Morere; Armando Santoro; Alberto Sobrero; Eric Van Cutsem; Alison Layton
Journal:  J Dtsch Dermatol Ges       Date:  2005-08       Impact factor: 5.584

4.  United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets.

Authors:  Martin H Cohen; Grant A Williams; Rajeshwari Sridhara; Gang Chen; W David McGuinn; David Morse; Sophia Abraham; Atiqur Rahman; Chenyi Liang; Richard Lostritto; Amy Baird; Richard Pazdur
Journal:  Clin Cancer Res       Date:  2004-02-15       Impact factor: 12.531

Review 5.  Skin toxicities associated with epidermal growth factor receptor inhibitors.

Authors:  Tianhong Li; Roman Perez-Soler
Journal:  Target Oncol       Date:  2009-05-19       Impact factor: 4.493

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.